Market Tracker weekly round-up—10 May 2019

Market Tracker weekly round-up—10 May 2019

Weekly round-up of the latest corporate announcements, including a reverse takeover by Venn Life Sciences Holdings, a possible IPO by Induction Healthcare Group plc, secondary offers by Attraqt Group plc and Brewin Dolphin Holdings plc, a related party transaction by Attraqt Group plc and an AGM notice from Primary Health Properties plc.

The weekly round-up covers all deals announced within our statement of scope until 12 noon on the Friday of the previous week. Any deals announced after this time will be included in the following day's round-up.

All transactions covered in this update are available on the Market Tracker deal analysis tool containing over 4,900 public company deal summaries.

The Market Tracker weekly bulletin looks in more detail at the latest transaction developments, mini trends and analysis of corporate deal documents. For trend reports and other analysis see our Trend Reports subtopic.

New deals (and AGMs) announced:


Announcement dateCompanyIndustry sectorKey information
7 May 2019Primary Health Properties plcInvestmentPrimary Health Properties announced that its 2019 AGM will be held on 11 June 2019.


Announcement dateIssuerIndustry sectorKey information
8 May 2019Induction Healthcare Group plcHealthcareInduction Healthcare announced a possible IPO on AIM. The company aims to raise £14.6 million in gross proceeds through the issue of 12,681,915 shares. The estimated market capitalisation of the company after admission is £34.1 million.

LR/AIM Rules transactions

Announcement dateCompanyIndustry sectorKey information
8 May 2019Attraqt Group plcComputing & ITAttraqt Group announced a related party transaction under the AIM rules.

Reverse takeovers

Announcement dateCompanyIndustry sectorKey information
10 May 2019Venn Life Sciences Holdings plc acquisition of Open Orphan DACHealthcareVenn Life Sciences announced that it conditionally agreed to acquire the entire issued and to be issued share capital of Open Orphan for an aggregate consideration of approximately £5.7 million, to be satisfied by the allotment and issue of new ordinary shares of 0.1 pence, subject to shareholder approval.Under the terms of the acquisition, new ordinary shares are expected to be issued to existing Open Orphan shareholders with reference to a relative value of Venn Life Sciences Holdings of approximately £4.0 million.

Secondary offers

Announcement dateIssuerIndustry sectorKey information
10 May 2019Brewin Dolphin Holdings plcFinancial ServicesBrewin Dolphin Holdings announced a placing to raise gross proceeds of £60 million, at a placing price of 305 pence per share. The placing will be conducted by way of an accelerated bookbuild.
8 May 2019Attraqt Group plcComputing & ITAttraqt Group announced a placing to raise £17.1 million in gross proceeds. The company announced that a total of 63,333,334 shares will be issued, at a price of 27 pence per share.


Related Articles:
Latest Articles:
About the author:

Market Tracker is a unique service for corporate lawyers housed within Lexis®PSL Corporate. It features a powerful transaction data analysis tool for accessing, analysing and comparing the specific features of corporate transactions, with a comprehensive and searchable library of deal documentation across 14 different deal types. The Market Tracker product also includes news and analysis of key corporate deals and activity and in-depth analysis of recent trends in corporate transactions.